In our study, HLA-DQA1 was also highly expressed in T1DM patients, suggesting that it may be involved in the pathogenesis of T1DM by inducing autoimmunity and could potentially be a therapeutic target. The gene discussed is HLA-DQA1; the disease is type 1 diabetes mellitus.